Author(s): Geerts H, Trojanowski JQ, Lee VM
Abstract Share this page
Abstract This meeting report documents the exciting ongoing research aimed at developing new therapeutic agents for neurodegenerative diseases at the interface between academia and industry, and illustrates the direction the NIH "roadmap" for medical research is taking. Some of the projects have resulted in very promising drugs, identified and developed by academic centers, entering clinical trials.
This article was published in Sci Aging Knowledge Environ
and referenced in Drug Designing: Open Access